Navigation Links
Scripps Research scientists awarded $2.2 million to develop treatment for multi-drug addiction
Date:6/9/2011

The Scripps Research Institute has been awarded a $2.2 million grant from the National Institutes of Health (NIH) to develop novel therapeutics for the treatment of addiction to multiple substances in a national effort with the University of Kansas.

The total award is for $3,698,130, with the Florida campus of Scripps Research receiving $2.19 million over five years and the University of Kansas receiving approximately $1.5 million.

According to the National Survey on Drug Use and Health, in 2009 an estimated 21.8 million Americans aged 12 or older had used illicit drugs within the last month, approximately 8.7 percent of the population aged 12 or older, an increase over 2008. Illicit drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, and prescription-type psychotherapeutics used nonmedically. Multiple drug use is common among substance abusers, according to the National Institute on Drug Abuse (NIDA).

The grant funds research directed by Scripps Research Associate Professor Laura Bohn to develop new compounds targeting a specific receptor playing a critical role in the persistence of compulsive drug seeking and taking. (Receptors bind substances, triggering certain biological effects.)

"All addictive drugs share certain reinforcing properties that make it difficult to quit and remain abstinent," said Bohn. "There is significant evidence spanning decades that the kappa opioid receptor is a good candidate in terms of disrupting this addictive cycle. Right now we're in the early stages of R&D but we have a lot of confidence in what we've studied so far."

The kappa opioid receptor, which is located on neurons, helps regulate the release of dopamine a neurotransmitter that plays a key role in drug addiction. Drugs of abuse often cause the brain to release large amounts of dopamine, flooding the brain's reward system and reinforcing the addictive cycle.

The basis of the studies proposed in the current award results from years of screening by the Molecular Libraries Probe Production Centers Network supported by the NIH. After screening more than 300,000 small molecule compounds, the group, along with the specialized chemistry center at the University of Kansas, identified five novel chemical candidates for clinical development.

For the next five years, the collaborative research team at Scripps Research and the University of Kansas will work to improve selectivity, potency, efficacy, and bioavailability of these compounds to provide a strong preclinical framework for clinical utilization of new drugs targeting the kappa opioid receptor in the hopes of finding a way to help improve recovery from a variety of addictive drugs.


'/>"/>

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Source:Eurekalert

Related biology news :

1. Scripps Research scientist wins $1.9 million grant to study malaria
2. Scripps Research scientists find way to block stress-related cell death
3. Scripps Research scientists find key mechanism in transition to alcohol dependence
4. Scripps Research scientists create new genetic model of premature aging diseases
5. Scripps Research scientists identify mechanism of long-term memory
6. Scripps Research scientists uncover new DNA role in modifying gene function
7. Scripps Research scientists find dual switch regulates fat formation
8. Common chaperone protein found to work in surprising way, say Scripps Research scientists
9. Dr. Daniel Von Hoff presented with top genomics award from Scripps
10. Scripps Research team discovers new details about medically important protein family
11. Scripps Research scientists develop new test for pluripotent stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2017)... Former 9/11 Commission border counsel and Special ... Kephart of Identity Strategy Partners, LLP, today releases ... "Executive Order: Protecting the Nation From Foreign Terrorist Entry ... "As President Trump,s ,Travel Ban, Executive Order gains more ... the travel ban, it is important that our national ...
(Date:2/8/2017)... 2017 About Voice Recognition Biometrics Voice recognition ... against a stored voiceprint template. Acoustic features of ... tone are compared to distinguish between individual voices. ... most PCs already have a microphone and can ... biometrics are most likely to be deployed in ...
(Date:2/8/2017)... 7, 2017 The biometrics market has ... confluence of organizations, desires to better authenticate or ... (password and challenge questions), biometrics is quickly working ... The market is driven by use cases, though ... and enterprise uses cases, with consumer-facing use cases ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017  Capricor Therapeutics, Inc. (NASDAQ: ... other medical conditions, today announced that Linda Marbán, Ph.D, president ... upcoming investor conferences: Cowen and Company ... 10:00 am ET Boston, MA ... at 9:00 am PT (12:00 pm ET) Dana ...
(Date:2/23/2017)... USA, and CARDIFF, UK (PRWEB) , ... February ... ... international society for optics and photonics , have been named Fellows of the ... significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, and ...
(Date:2/22/2017)... ... ... Park Systems , a leader in Atomic Force Microscopy (AFM) since ... attendees and Park customers on Feb. 27, 2017 from 12-2pm at Morton’s The Steakhouse ... The luncheon will feature a talk on Automated AFM for Small-Scale and Large-Scale Surface ...
(Date:2/22/2017)... Fort Washington, PA (PRWEB) , ... ... ... The Omnia-Prova Education Collaborative (TOPEC), the leading medical education provider of ... Accreditation with Commendation by the Accreditation Council for Continuing Medical Education (ACCME). ...
Breaking Biology Technology: